NVO Share Price

Open 38.52 Change Price %
High 38.89 1 Day 1.42 3.80
Low 38.05 1 Week 2.90 8.08
Close 38.78 1 Month 4.67 13.69
Volume 5889056 1 Year -17.26 -30.80
52 Week High 57.44
52 Week Low 30.89
NVO Important Levels
Resistance 2 39.56
Resistance 1 39.24
Pivot 38.57
Support 1 38.32
Support 2 38.00
NYSE USA Most Active Stocks
EMC 29.05 0.97%
EMC 29.05 0.97%
EMC 29.05 0.97%
SE 40.68 -0.78%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
PCS 11.84 -0.92%
BAC 23.65 -1.00%
BAC 23.65 -1.00%
BAC 23.65 -1.00%
More..
NYSE USA Top Gainers Stocks
POM 26.93 26.79%
POM 26.93 26.79%
GLF 0.34 25.93%
GLF 0.34 25.93%
FNP 35.24 12.02%
FNP 35.24 12.02%
MTL 5.76 11.63%
MTL 5.76 11.63%
CVI 21.96 11.53%
HF 31.88 11.51%
More..
NYSE USA Top Losers Stocks
ENL 15.81 -66.25%
ENL 15.81 -66.25%
ENL 15.81 -66.25%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
MHR 0.15 -42.31%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
STP 0.53 -39.77%
More..

Novo Nordisk A/S (NYSE: NVO)

NVO Technical Analysis 2
As on 27th Apr 2017 NVO Share Price closed @ 38.78 and we RECOMMEND Sell for LONG-TERM with Stoploss of 41.52 & Strong Buy for SHORT-TERM with Stoploss of 34.95 we also expect STOCK to react on Following IMPORTANT LEVELS.
NVO Target for April
1st Target up-side 35.51
2nd Target up-side 36.37
3rd Target up-side 37.23
1st Target down-side 33.05
2nd Target down-side 32.19
3rd Target down-side 31.33
NVO Other Details
Segment EQ
Market Capital 84204396544.00
Sector Healthcare
Industry Drug Manufacturers - Other
Offical website http://www.novonordisk.com
NVO Address
NVO
Novo All
Bagsvaerd, 2880
Denmark
Phone: 45 44 44 88 88
Fax: 45 44 49 05 55
NVO Latest News
Novo Nordisk A/S (ADR)(NYSE:NVO) Recognizes The Hemophilia Community   Market Exclusive   - 18th Apr 17
Is Novo Nordisk A/S (ADR)(NYSE: NVO) failing to meet expectations   FX Daily Report   - 08th Mar 17
Novo Nordisk: Market Leader Is On Sale - I'm Accumulating Shares In The Low $30s   Seeking Alpha   - 31st Dec 16
Portfolio Update - Novo Nordisk Purchased   Seeking Alpha   - 22nd Nov 16
Analyst's Report on: Novo Nordisk A/S (ADR) (NYSE:NVO)   Post Registrar   - 01st Nov 16
Analytical Approach on Price Target Estimates: Novo Nordisk A/S (ADR) (NYSE:NVO)   Post Registrar   - 27th Oct 16
Novo Nordisk to ax 1000 jobs as competition grows   MarketWatch   - 29th Sep 16
The Cryptic World of Oral Insulin, Novo Nordisk A/S (ADR) (NYSE:NVO) vs Oramed ...   Market Exclusive   - 09th Aug 16
Novo Nordisk A/S ADR NVO (US: NYSE)   Wall Street Journal   - 11th Feb 11
36.5098   MarketWatch   - 03rd Jul 09
Interactive Technical Analysis Chart Novo Nordisk A/S ( NVO NYSE USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Novo Nordisk A/S
NVO Business Profile
Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The Diabetes Care segment covers insulins, GLP-1 analog, obesity, and oral antidiabetic drugs, as well as other protein related products comprising glucagon, protein related delivery systems, and needles. The Biopharmaceuticals segment offers products in the areas of haemophilia, growth hormone therapy, hormone replacement therapy, and inflammation. The company sells its products primarily in North America, China, Japan, Algeria, Argentina, Australia, Brazil, India, Turkey, and European countries through its subsidiaries, distributors, and independent agents. Novo Nordisk A/S was founded in 1925 and is headquartered in Bagsvaerd, Denmark.